Novartis Doan's Hearing To Review FTC Ruling Set For Feb. 8
This article was originally published in The Tan Sheet
Executive Summary
Oral arguments on Novartis' petition for review of the Federal Trade Commission's corrective advertising order for Doan's pills are scheduled to be heard in D.C. federal appeals court Feb. 8.